- Trials with a EudraCT protocol (565)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
565 result(s) found for: Injection site pain.
Displaying page 5 of 29.
EudraCT Number: 2017-000709-18 | Sponsor Protocol Number: T2017-7 | Start Date*: 2018-07-02 |
Sponsor Name:Bernhoven | ||
Full Title: The effect of erector spinae block on postoperative pain and opioid use in patients undergoing breast cancer surgery with sentinel node dissection | ||
Medical condition: Patients undergoing unilateral (modified) mastectomy with sentinel node dissection for breast cancer | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-002428-34 | Sponsor Protocol Number: ANE-DEX-2019 | Start Date*: 2019-09-27 | |||||||||||
Sponsor Name:HOSPITAL CLINICO SAN CARLOS | |||||||||||||
Full Title: ONE CENTRE, DOUBLE BLIND, ONE CENTRE, RANDOMIZED CLINICAL TRIAL, IN TWO PARALLEL GROUPS TO EVALUATE THE EFICACY IN THE PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING OF DEXAMETHASONE VERSUS METHIL... | |||||||||||||
Medical condition: Postoperative nausea and vomiting after not urgent laparoscopic cholecystectomy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-004916-39 | Sponsor Protocol Number: 2015-806 | Start Date*: 2016-01-19 | |||||||||||
Sponsor Name:Digestive Disease Center, Bispebjerg Hospital | |||||||||||||
Full Title: PreOperative Steroid in Abdominal Wall Reconstruction: A Double-blinded Randomized Clinical Trial | |||||||||||||
Medical condition: Patients who undergo abdominal wall reconstruction for repair of a giant ventral hernia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-005442-42 | Sponsor Protocol Number: C4591007 | Start Date*: 2021-04-28 | |||||||||||
Sponsor Name:BioNTech SE | |||||||||||||
Full Title: A PHASE 1, OPEN-LABEL DOSE-FINDING STUDY TO EVALUATE SAFETY, TOLERABILITY, AND IMMUNOGENICITY AND PHASE 2/3 PLACEBOCONTROLLED, OBSERVER-BLINDED SAFETY, TOLERABILITY, AND IMMUNOGENICITY STUDY OF A S... | |||||||||||||
Medical condition: Protection against COVID-19 | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-003694-34 | Sponsor Protocol Number: 2-HIT | Start Date*: 2017-10-25 | ||||||||||||||||
Sponsor Name:Ziekenhuis Oost-Limburg | ||||||||||||||||||
Full Title: Onset and duration of Forearm nerve blockade performed with a single distal injection versus sequential injections at distal and proximal locations alongside the nerves: a blinded randomized contro... | ||||||||||||||||||
Medical condition: Dupuytren contrature and Carpal Tunnel syndrome | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-001342-15 | Sponsor Protocol Number: CACZ885H2361E1 | Start Date*: 2011-09-26 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A 36-week open-label extension study of CACZ885H2361 on the safety and tolerability of canakinumab 150 mg s.c. pre-filled syringe (PFS) in treating acute gouty arthritis flares in frequently flarin... | |||||||||||||
Medical condition: Evaluate the long-term safety, tolerability and immunogenicity of canakinumab 150 mg s.c. administered as pre-filled syringe (PFS). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LT (Completed) DE (Completed) HU (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-001159-20 | Sponsor Protocol Number: STH14404 | Start Date*: 2008-09-25 | ||||||||||||||||
Sponsor Name:Sheffield Teaching Hospitals NHS Foundation Trust | ||||||||||||||||||
Full Title: A Prospective, Multi-centre, Single-Arm, Open Label Study of the Long term Use of a LHRH Agonist (Decapeptyl® SR, 11.25 mg) in Combination with Livial® Add-back Therapy in the Management of Chronic... | ||||||||||||||||||
Medical condition: Chronic cyclical pelvic pain | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-002842-35 | Sponsor Protocol Number: 2018/07 | Start Date*: 2018-11-07 | |||||||||||
Sponsor Name:CMC Ambroise Paré | |||||||||||||
Full Title: Interest of parasternal block to prevent hypertensive and tachycardia episodes during sternotomy in patients undergoing coronary artery bypass graft | |||||||||||||
Medical condition: coronary artery bypass graft | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-003395-23 | Sponsor Protocol Number: HK_VL_08_2014 | Start Date*: 2015-01-20 | |||||||||||
Sponsor Name:Section for Surgical Pathophysiology, Rigshospitalet | |||||||||||||
Full Title: Effect of preoperative intravenous highdose methylprednisolone on quadriceps muscle function, endothelial function, complement activation and glucose homeostasis in patients scheduled for total kne... | |||||||||||||
Medical condition: Knee joint arthrosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-001139-98 | Sponsor Protocol Number: IC2021-07 | Start Date*: 2022-06-13 | ||||||||||||||||
Sponsor Name:Institut Curie | ||||||||||||||||||
Full Title: Opioid-Free versus Opioid-Based Anaesthesia for secondary free-flap reconstruction surgery of the breast: A phase III multicentric randomized controlled study | ||||||||||||||||||
Medical condition: Anaesthesia during secondary free flap reconstruction surgery of the breast. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||
Trial protocol: FR (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-000434-21 | Sponsor Protocol Number: PRT-PEG-15-10880 | Start Date*: 2016-11-14 | |||||||||||
Sponsor Name:Biogen Portugal | |||||||||||||
Full Title: PLENO – Open-label, Randomized, 2-arm, Active Comparator Study to Evaluate Safety and Tolerability in Portuguese Patients with Relapsing Remitting Multiple Sclerosis (MS) Transitioning from Current... | |||||||||||||
Medical condition: Relapsing-remitting multiple sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: PT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-003797-51 | Sponsor Protocol Number: D5680C00003 | Start Date*: 2021-07-20 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A Randomised, Double-blind, Placebo-controlled, Dose-response Study of the Efficacy and Safety of MEDI7352 in Subjects with Painful Osteoarthritis of the Knee | |||||||||||||
Medical condition: Painful osteoarthritis of the knee | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-005212-40 | Sponsor Protocol Number: MR080508 | Start Date*: 2008-10-14 | ||||||||||||||||||||||||||
Sponsor Name:Karolinska Institute | ||||||||||||||||||||||||||||
Full Title: Pain mechanisms and fatigue in rheumatoid arthritis (RA) and healthy volunteers. Can antirheumatic and biological therapy affect pain processing and fatigue in RA? | ||||||||||||||||||||||||||||
Medical condition: Rheumatoid arthritis (RA) The overall aim with this project is to investigate central pain mechanisms in RA and healthy controls, and in RA how these are influenced by autonomic neural regulation ... | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||||||||||||
Trial protocol: SE (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-002570-31 | Sponsor Protocol Number: APHP180560 | Start Date*: 2021-01-15 |
Sponsor Name:Assitance Publique - Hôpitaux de Paris | ||
Full Title: Randomized multicenter double-blind controlled trial comparing anakinra to prednisone for gout flare in patients with chronic kidney disease stage 4-5 or kidney transplantation | ||
Medical condition: Men and women of more than 18 years old with a stage 4 or 5 kidney insufficiency or or a kidney insufficiency and an untreated gout attack | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: FR (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2018-002523-42 | Sponsor Protocol Number: D5680C00002 | Start Date*: 2018-10-22 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A randomised, double-blind, placebo-controlled, dose-response study of the efficacy and safety of MEDI7352 in subjects with painful diabetic neuropathy | |||||||||||||
Medical condition: Painful diabetic neuropathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) ES (Prematurely Ended) PL (Prematurely Ended) HU (Prematurely Ended) DK (Completed) RO (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-004013-41 | Sponsor Protocol Number: AUH-TFB-SSPS-3 | Start Date*: 2015-09-18 | ||||||||||||||||
Sponsor Name:Thomas Fichnter Bendtsen | ||||||||||||||||||
Full Title: Supra Sacral Parallel Shift - ultrasound/MR image fusion guided lumbosacral plexus block | ||||||||||||||||||
Medical condition: | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-002835-27 | Sponsor Protocol Number: DRP-05-12 | Start Date*: 2012-09-07 |
Sponsor Name:Dr. Ritsert Pharma | ||
Full Title: Double-blind, randomized clinical study to determine the efficacy of Anestherit® 10% on histamine-induced pruritus and UVB-light induced slight sunburn in healthy subjects. | ||
Medical condition: Histamine-induced pruritus UVB-light-induced slight sunburn | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: AT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-001200-38 | Sponsor Protocol Number: OTIS2019_001 | Start Date*: 2020-11-17 | |||||||||||
Sponsor Name:Karolinska Universitetssjukhuset | |||||||||||||
Full Title: Octreotide treatment to improve nutritional recovery after surgery for patients with esophageal or gastric cancer, a prospective randomized open label phase II study - OTIS | |||||||||||||
Medical condition: Undesired weight loss after operation for esophageal or gastric cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-000431-32 | Sponsor Protocol Number: ORTHOUNION | Start Date*: 2017-05-25 | ||||||||||||||||
Sponsor Name:Universidad Autónoma de Madrid (U.A.M.) | ||||||||||||||||||
Full Title: A MULTI-CENTRE, OPEN-LABEL, RANDOMIZED, COMPARATIVE CLINICAL TRIAL OF TWO DIFFERENT DOSES OF BONE MARROW AUTOLOGOUS HUMAN MESENCHYMAL STEM CELLS PLUS BIOMATERIAL VERSUS ILIAC CREST AUTOLOGOUS GRAFT... | ||||||||||||||||||
Medical condition: Diaphyseal and/or metaphysodiaphyseal fractures (femur, tibia, humerus) with status of non-union | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) DE (Completed) FR (Ongoing) IT (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-004450-21 | Sponsor Protocol Number: EMR200136-570 | Start Date*: 2014-02-07 | |||||||||||
Sponsor Name:Merck Serono S.p.A. | |||||||||||||
Full Title: Multicenter, open-label, 12 weeks, phaseIV pRospectivE randomized study aimed at evaLuating whether sc IFN beta 1a (Rebif®) administered In the morning may affEct the severity of Flu-like syndrom... | |||||||||||||
Medical condition: relapsing multiple sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
